CV Sciences, Inc. Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-based Compensation Cost
CV Sciences, Inc. (CVSI) had Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-based Compensation Cost of $72.00 thousand as of 2025-12-31, per its 10-K filed 2026-03-26.
Financial Statements › Notes › Income Taxes › Components of Deferred Tax Assets and Liabilities › Components of Deferred Tax Assets › Deferred Tax Assets, Net › Deferred Tax Assets, Net of Valuation Allowance › Deferred Tax Assets, Gross › Deferred Tax Assets, Tax Deferred Expense
us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost · last filed 2026-03-26
- 2025-12-31: Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-based Compensation Cost $72.00K.
- 2024-12-31: Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-based Compensation Cost $101.00K.
- 2023-12-31: Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-based Compensation Cost $4.08M.
- 2022-12-31: Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-based Compensation Cost $4.42M.
| Period end | Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-based Compensation Cost |
|---|---|
| 2025-12-31 | $72.00K 10-K · filed 2026-03-26 |
| 2024-12-31 | $101.00K 10-K · filed 2026-03-26 |
| 2023-12-31 | $4.08M 10-K · filed 2025-03-27 |
| 2022-12-31 | $4.42M 10-K · filed 2024-03-29 |
| 2021-12-31 | $6.36M 10-K · filed 2023-03-30 |
| 2020-12-31 | $6.47M 10-K · filed 2022-04-04 |
| 2019-12-31 | $6.74M 10-K · filed 2021-03-19 |
| 2018-12-31 | $4.54M 10-K · filed 2020-03-30 |
| 2017-12-31 | $575.00K 10-K · filed 2019-03-12 |
| 2016-12-31 | $579.97K 10-K · filed 2018-03-30 |
| 2015-12-31 | $163.94K 10-K · filed 2017-03-31 |
| 2014-12-31 | $128.70K 10-K · filed 2016-04-14 |
| 2013-12-31 | $0.00 10-K · filed 2015-03-31 |